Impact of obesity on surgical and oncologic outcomes in patients with endometrial cancer treated with a robotic approach.
endometrial cancer
obesity
postoperative complications
robotic surgery
survival
Journal
The journal of obstetrics and gynaecology research
ISSN: 1447-0756
Titre abrégé: J Obstet Gynaecol Res
Pays: Australia
ID NLM: 9612761
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
06
04
2020
revised:
08
07
2020
accepted:
30
07
2020
pubmed:
21
8
2020
medline:
22
6
2021
entrez:
22
8
2020
Statut:
ppublish
Résumé
The surgical treatment of endometrial cancer (EC) can be more complicated in obese patients. Robotic surgery could simplify the surgical approach in these patients. The aim of our study was to compare the outcomes of robotic surgery in obese (body mass index ≥30 kg/m We performed a retrospective study on patients with EC benefitting from a robotic approach in our institution. The primary outcome was the 5-year overall survival (OS). We also assessed the 5-year recurrence-free survival (RFS), type of surgery, laparotomy conversion rate, adjuvant treatment and postoperative morbidity. We analyzed 175 consecutive patients with EC who underwent robotic surgery, 42 patients with obesity and 133 patients without. The median follow-up length was 37 months [1-120]. The OS rate was 97% in the whole population and the RFS was 74%. Obesity did not impact prognosis. Laparotomy conversion rate was low in both groups (5% in patients with obesity vs 3%, P = 0.619). There were no significant differences in terms of postoperative complications (5 vs 9%, P = 0.738). There were significantly less pelvic lymphadenectomies in patients with obesity (5 vs 12%, P = 0.005). In the subgroup of patients with high-risk EC, rate of lymphadenectomy and of adjuvant treatments did not differ between patients with or without obesity. Obese patients with EC can be safely treated with a robotic approach, with a low complication rate and similar oncological outcomes compared to nonobese patients.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
128-136Informations de copyright
© 2020 Japan Society of Obstetrics and Gynecology.
Références
Wise MR, Jordan V, Lagas A et al. Obesity and endometrial hyperplasia and cancer in premenopausal women: A systematic review. Am J Obstet Gynecol 2016; 214: 689.e1-689.e17.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 2008; 371: 569-578.
Colombo N, Creutzberg C, Amant F et al. ESMO-ESGO-ESTRO consensus conference on endometrial cancer: Diagnosis, treatment and follow-up. Int J Gynecol Cancer 2016; 26: 2-30.
NCCN - Evidence-Based Cancer Guidelines, Oncology Drug Compendium, Oncology Continuing Medical Education [Internet] [Cited 17 May 2020.]. Available from URL: https://www.nccn.org/
Walker JL, Piedmonte MR, Spirtos NM et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol 2012; 30: 695-700.
Gunderson CC, Java J, Moore KN, Walker JL. The impact of obesity on surgical staging, complications, and survival with uterine cancer: A Gynecologic Oncology Group LAP2 ancillary data study. Gynecol Oncol 2014; 133: 23-27.
Lin LL, Hertan L, Rengan R, Teo B-KK. Effect of body mass index on magnitude of setup errors in patients treated with adjuvant radiotherapy for endometrial cancer with daily image guidance. Int J Radiat Oncol Biol Phys 2012; 83: 670-675.
Bouwman F, Smits A, Lopes A et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery - an institutional study and systematic review of the literature. Gynecol Oncol 2015; 139: 369-376.
Gallotta V, Conte C, D'Indinosante M. Robotic surgery in elderly and very elderly gynecologic cancer patients. J Minim Invasive Gynecol 2018; 25: 872-877.
Gallotta V, D'Indinosante M, Nero C. Robotic splenectomy for isolated splenic recurrence of endometrial adenocarcinoma. J Minim Invasive Gynecol 2018; 25: 774-775.
Ran L, Jin J, Xu Y, Bu Y, Song F. Comparison of robotic surgery with laparoscopy and laparotomy for treatment of endometrial cancer: A meta-analysis. PLoS One 2014; 9: e108361.
Cusimano MC, Simpson AN, Dossa F et al. Laparoscopic and robotic hysterectomy in endometrial cancer patients with obesity: A systematic review and meta-analysis of conversions and complications. Am J Obstet Gynecol 2019; 221: 410-428 e19.
Gala RB, Margulies R, Steinberg A et al. Systematic review of robotic surgery in gynecology: Robotic techniques compared with laparoscopy and laparotomy. J Minim Invasive Gynecol 2014; 21: 353-361.
Dindo D, Demartines N, Clavien P-A. Classification of surgical complications: A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-213.
Ngô C, Cornou C, Rossi L et al. Evidence for the use of robotically assisted surgery in gynecologic cancers. Curr Opin Oncol 2016; 28: 398-403.
Gallotta V, Federico A, Gaballa K et al. The role of robotic aortic lymphadenectomy in gynecological cancer: Surgical and oncological outcome in a single institution experience. J Surg Oncol 2019; 119: 355-360.
Gallotta V, Giudice MT, Conte C et al. Minimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series. Eur J Surg Oncol 2018; 44: 1568-1572.
Suidan RS, He W, Sun CC et al. Impact of body mass index and operative approach on surgical morbidity and costs in women with endometrial carcinoma and hyperplasia. Gynecol Oncol 2017; 145: 55-60.
Stephan J-M, Goodheart MJ, McDonald M et al. Robotic surgery in supermorbidly obese patients with endometrial cancer. Am J Obstet Gynecol 2015; 213: 49.e1-49.e8.
Lau S, Buzaglo K, Vaknin Z et al. Relationship between body mass index and robotic surgery outcomes of women diagnosed with endometrial cancer. Int J Gynecol Cancer 2011; 21: 722-729.
Walker JL, Piedmonte MR, Spirtos NM et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol 2009; 27: 5331-5336.
Corrado G, Vizza E, Cela V et al. Laparoscopic versus robotic hysterectomy in obese and extremely obese patients with endometrial cancer: A multi-institutional analysis. Eur J Surg Oncol 2018; 44: 1935-1941.
Lamvu G, Zolnoun D, Boggess J, Steege JF. Obesity: Physiologic changes and challenges during laparoscopy. Am J Obstet Gynecol 2004; 191: 669-674.
Grieco DL, Anzellotti GM, Russo A et al. Airway closure during surgical pneumoperitoneum in obese patients. Anesthesiology 2019; 131: 58-73.
Arem H, Irwin ML. Obesity and endometrial cancer survival: A systematic review. Int J Obes 2013; 37: 634-639.
Secord AA, Hasselblad V, Von Gruenigen VE et al. Body mass index and mortality in endometrial cancer: A systematic review and meta-analysis. Gynecol Oncol 2016; 140: 184-190.
Canlorbe G, Bendifallah S, Raimond E et al. Severe obesity impacts recurrence-free survival of women with high-risk endometrial cancer: Results of a French multicenter study. Ann Surg Oncol 2015; 22: 2714-2721.
Matta J, Zins M, Feral-Pierssens AL, Carette C. Prévalence du surpoids, de l'obésité et des facteurs de risque cardio-métaboliques dans la cohorte Constances. Bull Epidémiol Hebd 2016; 35-36: 640-646.